op Bruinink, D. H., Oliva, S., Rihova, L., Schmitz, A., Gilestro, M., te Marvelde, J., Kralova, R., Høholt, H., Broijl, A., Johnsen, H. E., Hajek, R., Boccadoro, M., Sonneveld, P., Omedè, P. and van der Velden, V. H. (2020) “Standardization of flow cytometric minimal residual disease assessment in international clinical trials. A feasibility study from the European Myeloma Network”, Haematologica. Pavia, Italy, 106(5), pp. 1496-1499. doi: 10.3324/haematol.2020.267831.